|
2014 Book Chapter Erythropoiesis stimulating agent resistanceO'Shea, Stacey, Badve, Sunil V. and Johnson, David W. (2014). Erythropoiesis stimulating agent resistance. Advances in drug resistance research. (pp. 120-135) edited by Christudas Morais. New York, NY, United States: Nova Science Publishers. |
|
2014 Conference Publication Research priorities in chronic kidney disease: a priority setting partnershipTong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. |
|
2014 Conference Publication Feasibility and construct validity of a frailty index for patients with chronic kidney diseaseSmith, Morgan, Peel, Nancye, Dawson, Blake, Lambat, Zahed, Bak, Melissa, Johnson, David W. and Hubbard, Ruth E. (2014). Feasibility and construct validity of a frailty index for patients with chronic kidney disease. Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting, Melbourne, VIC, Australia, 28–30 May 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/ajag.12177 |
|
2014 Conference Publication Progression to chronic kidney disease after acute kidney injury involves prolonged oxidative stress and persistent tubular metabolic alterationsSmall, D. M., Sanchez, W. Y., Roy, S. F., Morais, C., Johnson, D. W. and Gobe, G. C. (2014). Progression to chronic kidney disease after acute kidney injury involves prolonged oxidative stress and persistent tubular metabolic alterations. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25–27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301 |
|
2014 Journal Article Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials NetworkMorrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391 |
|
2014 Conference Publication Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patientsZhang, L., Badve, S. V., Pascoe, E. M., Beller, E., Cass, A., Clark, C., De Zoysa, J., Isbel, N. M., Mctaggart, S., Morrish, A. T., Playford, E. G., Scaria, A., Snelling, P., Vergara, L. A., Hawley, C. M., Johnson, D. W. and Honeypot Study Collaborative Group (2014). Microbiological results of the Honeypot Study - Secondary analysis of a randomised, controlled trial of exit site application of Medihoney for the prevention of catheter-associated infections in Pd patients. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301 |
|
2014 Conference Publication Tacrolimus Toxicity From Nilutamide Co-Administration: a Case ReportKennard, A., Johnson, D. and Hawley, C. (2014). Tacrolimus Toxicity From Nilutamide Co-Administration: a Case Report. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Hoboken, NJ United States: Wiley-Blackwell. |
|
2014 Journal Article Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomesCho, Yeoungjee and Johnson, David W. (2014). Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes. American Journal of Kidney Diseases, 64 (2), 278-289. doi: 10.1053/j.ajkd.2014.02.025 |
|
2014 Conference Publication A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero TrialJohnson, D. W., Pascoe, E., Badve, S. V., Dalziel, K., Cass, A., Clarke, P., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Scaria, A., Walker, R., Vergara, L. A. and Hawley, C. M. (2014). A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial. Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.12301 |
|
2014 Conference Publication Assessment of Current Practice and Barriers to Antimicrobial Prophylaxis in Peritoneal Dialysis PatientsCampbell, D. J., Brown, F., Craig, J., Gallagher, M., Johnson, D. W., Kirkland, G., Kumar, S. K., Lim, W. H., Ranganathan, D., Saweirs, W., Sud, K., Toussaint, N. D., Walker, R. G., Yehia, M. and Mudge, D. W. (2014). Assessment of Current Practice and Barriers to Antimicrobial Prophylaxis in Peritoneal Dialysis Patients. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC Australia, 25 - 27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301 |
|
2014 Conference Publication The effect of pentoxifylline on oxidative stress markers: substudy of the hero trialZhang, L., Pascoe, E. M., Badve, S. V., Cass, A., Clarke, P., Coombes, J. S., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L. A., Hawley, C. M. and Johnson, D. W. (2014). The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25-27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301 |
|
2014 Book Chapter Anaemia: prevalence, risk factors and management with a focus on chronic kidney diseaseAbdul Razak, K., Mudge, D. W. and Johnson, D. W. (2014). Anaemia: prevalence, risk factors and management with a focus on chronic kidney disease. Anemia: prevalence, risk factors and management strategies. (pp. 123-146) Hauppauge, NY United States: Nova Science Publishers. |
|
2014 Journal Article Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell linesBennett, Nigel C., Hooper, John D., Johnson, David W. and Gobe, Glenda C. (2014). Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Prostate, 74 (5), 478-487. doi: 10.1002/pros.22767 |
|
2014 Journal Article The association between peritoneal dialysis modality and peritonitisLan, Patrick G., Johnson, David W., McDonald, Stephen P., Boudville, Neil, Borlace, Monique, Badve, Sunil V., Sud, Kamal and Clayton, Philip A. (2014). The association between peritoneal dialysis modality and peritonitis. Clinical Journal of the American Society of Nephrology, 9 (6), 1091-1097. doi: 10.2215/CJN.09730913 |
|
2014 Conference Publication Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd SpectrumRossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley. |
|
2014 Journal Article Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trialJohnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5 |
|
2013 Journal Article A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitisSalimi, Maryam, Barlow, Jillian L., Saunders, Sean P., Xue, Luzheng, Gutowska-Owsiak, Danuta, Wang, Xinwen, Huang, Li-Chieh, Johnson, David, Scanlon, Seth T., McKenzie, Andrew N. J., Fallon, Padraic G. and Ogg, Graham S. (2013). A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. Journal of Experimental Medicine, 210 (13), 2939-2950. doi: 10.1084/jem.20130351 |
|
2013 Journal Article Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney diseaseRossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., Weston, K.S., Hawley, C.M., McWhinney, B.C., Ungerer, J.P.J. and Isbel, N. (2013). Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease. Archives of Medical Research, 45 (4), 309-317. doi: 10.1016/j.arcmed.2014.04.002 |
|
2013 Journal Article Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patientsLi, Philip K.T., Culleton, Bruce F., Ariza, Amaury, Do, Jun-Young, Johnson, David W., Sanabria, Mauricio, Shockley, Ty R., Story Ken, Vatazin, Andrey, Verrelli, Mauro, Yu, Alex W. and Bargman, Joanne M. (2013). Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. Journal of the American Society of Nephrology, 24 (11), 1889-1900. doi: 10.1681/ASN.2012100987 |
|
2013 Journal Article The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patientsCho, Yeoungjee, Johnson, David W., Badve, Sunil V., Craig, Jonathan C., Strippoli, Giovanni F. M. and Wiggins, Kathryn J. (2013). The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney International, 84 (5), 969-979. doi: 10.1038/ki.2013.190 |
